Looking for 50847-11-5 / Ibudilast API manufacturers, exporters & distributors?
Ibudilast manufacturers, exporters & distributors
1
20
PharmaCompass offers a list of Ibudilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibudilast manufacturer or Ibudilast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibudilast manufacturer or Ibudilast supplier.
PharmaCompass also assists you with knowing the Ibudilast API Price utilized in the formulation of products. Ibudilast API Price is not always fixed or binding as the Ibudilast Price is obtained through a variety of data sources. The Ibudilast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
API | Excipient name
Ibudilast
Synonyms
50847-11-5, Ketas, Kc-404, Mn-166, Ibudilastum, Ke tas
Unique Ingredient Identifier (UNII)
M0TTH61XC5
About Ibudilast
Ibudilast is an orally bioavailable inhibitor of cyclic nucleotide phosphodiesterase (PDE), mainly PDE-3, -4, -10, and -11, with anti-(neuro)inflammatory, vasorelaxant, bronchodilator, analgesic, neuroprotective and potential anti-tumor activities. Ibudilast (IBD) is able to cross the blood-brain barrier (BBB). Upon administration, IBD exerts its potential anti-tumor activity against glioblastoma multiforme (GBM) cells by inhibiting PDE-4 and the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF), which results in a decrease in MIF, its receptor CD74, and AKT expression, and attenuates the immunosuppressive properties of monocytic myeloid-derived suppressor cells (MDSCs) and reduces T-regulatory cells (Tregs). This causes GBM cell apoptosis and inhibits GBM cell proliferation. In addition, IBD reduces, through its inhibitory effect on various PDEs, the production of certain pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL- 1beta, leukotriene B4, and tumor necrosis factor-alpha (TNF-a). IBD also upregulates the anti-inflammatory cytokine (IL-10), and promotes the production of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-4 (NT-4). It also blocks toll-like receptor-4 (TLR-4), inhibits nitric oxide (NO) synthesis and reduces the level of reactive oxygen species (ROS). It also prevents platelet aggregation, causes cerebral vasodilation, bronchial smooth muscle relaxation, and improves cerebral blood flow. In addition, IBD attenuates the PDE-mediated activation of glial cells and abrogates PDE-mediated neuroinflammation and neurodegeneration. MIF is secreted by cancer stem cells (CSCs) and is highly expressed within GBM and plays a key role in tumor cell proliferation. Co-expression of MIF and CD74 in GBM is associated with poor patient survival.